BioSpace News Archive

McKesson High Volume Solutions (HVS) and Coborn’s are pleased to announce the integration of ExpressRx Track with Coborn’s pharmacy operations.

Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced the dosing of the first Alzheimer’s disease patient in the Phase 1b portion of the INTERCEPT clinical study of AL003.

Arcadia Analytics’ value-based care insights cited as key factor in earning top marks from surveyed customers [31-January-2020] BURLINGTON, Mass. , Jan. 31, 2020 /PRNewswire/ -- Arcadia ( arcadia.io ), a widely-recognized leader in population health management, today announced that the company was awarded the 2020 Best in KLAS designation for Value-Based Care Managed

Eli Lilly and Company (NYSE: LLY) announced today that REYVOW™ (lasmiditan) C-V 50 mg and 100 mg tablets, an oral medication for the acute treatment of migraine with or without aura in adults, is now available for prescription

Annovis Bio, Inc. (NYSE American: ANVS), a clinical stage, drug platform company addressing Alzheimer’s, Parkinson’s and other neurodegenerative diseases, today announced the closing of its initial public offering of 2,000,000 shares of its common stock at the public offering price of $6.00 per share, and the full exercise by the underwriters of their option to purchase 300,000 additional shares of Annovis Bio’s common stock.

HandyClean™ Steridol® Wipes has demonstrated effectiveness against viruses similar to 2019 Novel Coronavirus (2019-nCoV) on hard, non-porous surfaces, and can be used against 2019 Novel Coronavirus

Centene Corporation (NYSE: CNC) announced today the launch of a new community partnership in Louisiana. Social Health Bridge, established in 2019 to help community based organizations and healthcare entities work more effectively to address social determinants of health, partnered with the NHP Foundation (NHPF) and its affiliate

Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today the successful initial verification of its screening test designed to identify the presence of the novel coronavirus that originated in China before spreading across the world, and that the test will soon be ready for validation in and subsequent distribution to any appropriate venue across the globe.

Maxar Technologies, a trusted partner and innovator in Earth Intelligence and Space Infrastructure, announced that it was selected by NASA to perform an in-space assembly demonstration using a lightweight robotic arm.

Bristol-Myers Squibb Company (NYSE:BMY) today announced that the company has withdrawn its application in the European Union (EU) for the combination of Opdivo (nivolumab) and Yervoy (ipilimumab) for the treatment of advanced non-small cell lung cancer (NSCLC) based on data from CheckMate -227.